The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial

Jurgens, MS; Safy-Khan, M; de Hair, MJH; Bijlsma, JWJ; Welsing, PMJ; Tekstra, J; Lafeber, FPJG; Sasso, EH; Jacobs, JWG

Safy-Khan, M (corresponding author), Univ Utrecht, Dept Rheumatol & Clin Immunol, Univ Med Ctr Utrecht, G02-228,POB 85500, NL-3508 GA Utrecht, Netherlands.

ARTHRITIS RESEARCH & THERAPY, 2020; 22 (1):

Abstract

Objectives The CAMERA-II trial compared two tight-control, treat-to-target strategies, initiating methotrexate with prednisone (MTX+pred) or MTX with ......

Full Text Link